tiprankstipranks
Urogen Pharma (DE:UR8)
FRANKFURT:UR8

Urogen Pharma (UR8) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
6Neutral
12Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Urogen Pharma’s (UR8) Moving Averages Convergence Divergence (MACD) indicator is -0.51, suggesting Urogen Pharma is a Buy.
Urogen Pharma’s (UR8) 20-Day exponential moving average is 14.54, while Urogen Pharma’s (UR8) share price is €13.6, making it a Sell.
Urogen Pharma’s (UR8) 50-Day exponential moving average is 14.73, while Urogen Pharma’s (UR8) share price is €13.6, making it a Sell.

Urogen Pharma (UR8) Pivot Points

May 05, 2024, 04:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.80
13.80
13.80
13.80
13.80
13.80
13.80
Fibonacci
13.80
13.80
13.80
13.80
13.80
13.80
13.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Urogen Pharma (UR8) Moving Averages

May 05, 2024, 04:52 AM
Period
Simple
Exponential
MA5
14.06Sell
13.93Sell
MA10
13.61Sell
14.09Sell
MA20
14.75Sell
14.54Sell
MA50
15.23Sell
14.73Sell
MA100
13.75Sell
14.18Sell
MA200
13.53Buy
13.34Buy
Urogen Pharma’s (UR8) 10-Day exponential moving average is 14.09, while Urogen Pharma’s (UR8) share price is €13.6, making it a Sell.
Urogen Pharma’s (UR8) 100-Day exponential moving average is 14.18, while Urogen Pharma’s (UR8) share price is €13.6, making it a Sell.
Urogen Pharma’s (UR8) stock price is €13.6 and Urogen Pharma’s (UR8) 50-day simple moving average is 15.23, creating a Sell signal.
Urogen Pharma’s (UR8) stock price is €13.6 and Urogen Pharma’s (UR8) 100-day simple moving average is 13.75, creating a Sell signal.
Urogen Pharma’s (UR8) stock price is €13.6 and Urogen Pharma’s (UR8) 200-day simple moving average is 13.53, creating a Buy signal.

Urogen Pharma (UR8) Technical Indicators

May 05, 2024, 04:52 AM
Name
Value
Implied Action
RSI (14)
42.33
Neutral
STOCH (9,6)
49.35
Neutral
STOCHRSI (14)
37.95
Neutral
MACD (12,26)
-0.51
Buy
ADX (14)
21.36
Neutral
Williams %R
-78.13
Buy
CCI (14)
-65.48
Neutral
ATR (14)
0.57
-
Ultimate Oscillator
48.48
Neutral
ROC
-15.53
Sell
Urogen Pharma’s (UR8) Relative Strength Index (RSI) is 42.33, creating a Neutral signal.
Urogen Pharma’s (UR8) Trend Strength Indicator (ADX) is 21.36, creating a Neutral signal.
Urogen Pharma’s (UR8) Commodity Channel Index (CCI) is -65.48, creating a Neutral signal.
Urogen Pharma’s (UR8) Price Rate of Change (ROC) is -15.53, creating a Sell signal.

FAQ

Is UR8 a Buy, Hold, or Sell?
Based on UR8’s technical indicators, UR8 is a Sell.
    What is UR8’s RSI (14)?
    UR8’s RSI (14) is 42.33, which suggests UR8 is a Neutral.
      What is UR8’s MACD?
      UR8’s MACD is -0.51, which suggests UR8 is a Buy.
        What is UR8’s 5-day moving average?
        UR8’s 5-day moving average is 14.06, which suggests UR8 is a Sell.
          What is UR8’s 20-day moving average?
          UR8 20-day moving average is 14.75, which suggests UR8 is a Sell.
            What is UR8’s 50-day moving average?
            UR8’s 50-day moving average is 15.23, which suggests UR8 is a Sell.
              What is UR8’s 200-day moving average?
              UR8’s 200-day moving average is 13.53, which suggests UR8 is a Buy.
                What is UR8’s Williams % R (14)?
                UR8’s Williams % R (14) is -78.13, which suggests UR8 is a Buy.
                  What is UR8’s CCI (14)?
                  UR8’s CCI (14) is -65.48, which suggests UR8 is a Neutral.
                    What is the share price of Urogen Pharma?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis